市場調查報告書
商品編碼
1451711
2024-2032 年按類型、技術(微陣列、即時定量聚合酶鍊式反應、定序技術)、應用、最終用戶和地區分類的轉錄組學市場報告Transcriptomics Market Report by Type, Technology (Microarray, Real-Time Quantitative Polymerase Chain Reaction, Sequencing Technologies), Application, End User, and Region 2024-2032 |
2023年,全球轉錄組學市場規模達到72億美元。展望未來, IMARC Group預計到2032年市場規模將達到118億美元,2024-2032年複合年成長率(CAGR)為5.44%。
轉錄組學是對任何生物的基因型在特定時間、條件或細胞產生的核糖核酸 (RNA) 轉錄本的分析。它將基因組、蛋白質組和細胞表現型連結起來。轉錄組學涵蓋與 RNA 相關的一切,包括它們的轉錄和表達水平、功能、位置、運輸和分解。轉錄組學利用微陣列分析、即時定量聚合酶鍊式反應 (Q-PCR) 和定序技術來確定基因的轉錄結構。它還幫助研究人員表徵轉錄活性,重點關注相關目標基因和轉錄本的子集,並識別響應和抵消生物和非生物環境脅迫的基因和途徑。
全球對個人化醫療的需求不斷成長,為市場創造了積極的前景。由於 PCR 應用數量的增加以及該領域的進步(例如 RNA 定序的廣泛使用),轉錄組學得到了廣泛的應用。與此一致的是,在研究應用中獲取遺傳資訊對RNA定序的需求不斷成長也有利於市場的成長。 RNA 定序徹底改變了轉錄組分析,能夠在單一研究中量化基因表現水平,以及新基因、剪接亞型、融合轉錄本的親和力,以及對非編碼 RNA 領域的非凡研究。除此之外,主要參與者不斷致力於開發疾病和診斷的新穎儀器和技術,這反過來又促進了市場成長。此外,推出具有全轉錄組定序 (WTS) 功能的先進基因分析產品,可提供詳細的 RNA 定序分析,對市場成長產生了積極影響。除此之外,廣泛的研究和開發(R&D)活動、由於Covid-19疾病的爆發而對轉錄組學的需求不斷增加,以及各種政府舉措和組學資金的實施正在支持市場的成長。
The global transcriptomics market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.44% during 2024-2032.
Transcriptomics is the analysis of the ribonucleic acid (RNA) transcripts produced by the genotype of any organism at a specific time, condition, or cell. It links the genome, the proteome, and the cellular phenotype. Transcriptomics encompasses everything relating to RNAs, including their transcription and expression levels, functions, locations, trafficking, and degradation. Transcriptomics utilizes microarray analysis, real-time quantitative polymerase chain reaction (Q-PCR), and sequencing technologies to determine the transcriptional structure of genes. It also assists researchers in characterizing transcriptional activity, focuses on a subset of relevant target genes and transcripts, and identifies genes and pathways that respond to and counteract biotic and abiotic environmental stresses.
The increasing demand for personalized medicine across the globe is creating a positive outlook for the market. Transcriptomics is widely used due to the rising number of PCR applications and the improvements in the field, such as the widespread usage of RNA sequencing. In line with this, the rising demand for RNA sequencing in research applications to obtain genetic information is also favoring the market growth. RNA sequencing has completely transformed transcriptome analysis, enabling the quantification of gene expression levels in a single study and the affinity of new genes, splice isoforms, fusion transcripts, and extraordinary research into the world of non-coding RNA. Apart from this, key players are constantly focusing on developing novel instruments and techniques in diseases and diagnosis, which, in turn, is augmenting the market growth. Additionally, the launch of an advanced gene profiling product with whole transcriptome sequencing (WTS) that can provide detailed RNA sequencing analysis is positively influencing the market growth. Besides this, extensive research and development (R&D) activities, increasing demand for transcriptomics due to the outbreak of the Covid-19 disease, and the implementation of various government initiatives and funding for omics are supporting the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global transcriptomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, technology, application and end user.
Instruments
Consumables
Software
Services
Microarray
Real-Time Quantitative Polymerase Chain Reaction (Q-PCR)
Sequencing Technologies
Diagnostics and Disease Profiling
Drug Discovery
Others
Academic and Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Becton Dickinson and Company, BGI Group, Bio-Rad Laboratories Inc., Biospyder Technologies Inc., Illumina Inc., Nanostring Technologies Inc., Qiagen, Roche Holding AG, Takara Bio Inc. and Thermo Fisher Scientific Inc. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.